Low lopinavir plasma or hair concentrations explain second-line protease inhibitor failures in a resource-limited setting.

Hdl Handle:
http://hdl.handle.net/10144/141404
Title:
Low lopinavir plasma or hair concentrations explain second-line protease inhibitor failures in a resource-limited setting.
Authors:
van Zyl, Gert Uves; van Mens, Thijs E; McIlleron, Helen; Zeier, Michele; Nachega, Jean B; Decloedt, Eric; Malavazzi, Carolina; Smith, Peter; Huang, Yong; van der Merwe, Lize; Gandhi, Monica; Maartens, Gary
Journal:
Journal of Acquired Immune Deficiency Syndromes (1999)
Abstract:
In resource-limited settings, many patients, with no prior protease inhibitor (PI) treatment on a second-line, high genetic barrier, ritonavir-boosted PI-containing regimen have virologic failure.
Affiliation:
Division of Medical Virology, Department of Pathology, NHLS Tygerberg and Stellenbosch University, Tygerberg, South Africa. guvz@sun.ac.za
Issue Date:
Apr-2011
URI:
http://hdl.handle.net/10144/141404
DOI:
10.1097/QAI.0b013e31820dc0cc
PubMed ID:
21239995
Language:
en
ISSN:
1944-7884
Appears in Collections:
HIV/AIDS

Full metadata record

DC FieldValue Language
dc.contributor.authorvan Zyl, Gert Uvesen
dc.contributor.authorvan Mens, Thijs Een
dc.contributor.authorMcIlleron, Helenen
dc.contributor.authorZeier, Micheleen
dc.contributor.authorNachega, Jean Ben
dc.contributor.authorDecloedt, Ericen
dc.contributor.authorMalavazzi, Carolinaen
dc.contributor.authorSmith, Peteren
dc.contributor.authorHuang, Yongen
dc.contributor.authorvan der Merwe, Lizeen
dc.contributor.authorGandhi, Monicaen
dc.contributor.authorMaartens, Garyen
dc.date.accessioned2011-08-31T20:40:26Z-
dc.date.available2011-08-31T20:40:26Z-
dc.date.issued2011-04-
dc.identifier.citationLow lopinavir plasma or hair concentrations explain second-line protease inhibitor failures in a resource-limited setting. 2011, 56 (4):333-9 J. Acquir. Immune Defic. Syndr.en
dc.identifier.issn1944-7884-
dc.identifier.pmid21239995-
dc.identifier.doi10.1097/QAI.0b013e31820dc0cc-
dc.identifier.urihttp://hdl.handle.net/10144/141404-
dc.description.abstractIn resource-limited settings, many patients, with no prior protease inhibitor (PI) treatment on a second-line, high genetic barrier, ritonavir-boosted PI-containing regimen have virologic failure.en
dc.language.isoenen
dc.rightsArchived with thanks to Journal of Acquired Immune Deficiency Syndromes (1999)en
dc.subject.meshAdulten
dc.subject.meshAnti-HIV Agentsen
dc.subject.meshCase-Control Studiesen
dc.subject.meshCross-Sectional Studiesen
dc.subject.meshDrug Resistance, Viralen
dc.subject.meshFemaleen
dc.subject.meshHIV Infectionsen
dc.subject.meshHairen
dc.subject.meshHumansen
dc.subject.meshMaleen
dc.subject.meshMiddle Ageden
dc.subject.meshPlasmaen
dc.subject.meshPyrimidinonesen
dc.subject.meshRNA, Viralen
dc.subject.meshSouth Africaen
dc.subject.meshTreatment Failureen
dc.subject.meshViral Loaden
dc.titleLow lopinavir plasma or hair concentrations explain second-line protease inhibitor failures in a resource-limited setting.en
dc.contributor.departmentDivision of Medical Virology, Department of Pathology, NHLS Tygerberg and Stellenbosch University, Tygerberg, South Africa. guvz@sun.ac.zaen
dc.identifier.journalJournal of Acquired Immune Deficiency Syndromes (1999)en

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.